Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Identification of KIAA1199 as a Biomarker for Pancreatic Intraepithelial Neoplasia.

Suh HN, Jun S, Oh AY, Srivastava M, Lee S, Taniguchi CM, Zhang S, Lee WS, Chen J, Park BJ, Park JI.

Sci Rep. 2016 Dec 6;6:38273. doi: 10.1038/srep38273.

2.

A holistic approach to dissecting SPARC family protein complexity reveals FSTL-1 as an inhibitor of pancreatic cancer cell growth.

Viloria K, Munasinghe A, Asher S, Bogyere R, Jones L, Hill NJ.

Sci Rep. 2016 Nov 25;6:37839. doi: 10.1038/srep37839.

3.

Radiation promotes epithelial-to-mesenchymal transition and invasion of pancreatic cancer cell by activating carcinoma-associated fibroblasts.

Li D, Qu C, Ning Z, Wang H, Zang K, Zhuang L, Chen L, Wang P, Meng Z.

Am J Cancer Res. 2016 Oct 1;6(10):2192-2206.

4.

Epithelial to Stromal Re-Distribution of Primary Cilia during Pancreatic Carcinogenesis.

Schimmack S, Kneller S, Dadabaeva N, Bergmann F, Taylor A, Hackert T, Werner J, Strobel O.

PLoS One. 2016 Oct 26;11(10):e0164231. doi: 10.1371/journal.pone.0164231.

5.

Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.

Leca J, Martinez S, Lac S, Nigri J, Secq V, Rubis M, Bressy C, Sergé A, Lavaut MN, Dusetti N, Loncle C, Roques J, Pietrasz D, Bousquet C, Garcia S, Granjeaud S, Ouaissi M, Bachet JB, Brun C, Iovanna JL, Zimmermann P, Vasseur S, Tomasini R.

J Clin Invest. 2016 Nov 1;126(11):4140-4156. doi: 10.1172/JCI87734.

PMID:
27701147
6.

Generation of an in vitro 3D PDAC stroma rich spheroid model.

Ware MJ, Keshishian V, Law JJ, Ho JC, Favela CA, Rees P, Smith B, Mohammad S, Hwang RF, Rajapakshe K, Coarfa C, Huang S, Edwards DP, Corr SJ, Godin B, Curley SA.

Biomaterials. 2016 Nov;108:129-42. doi: 10.1016/j.biomaterials.2016.08.041.

PMID:
27627810
7.

Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts.

Arcucci A, Ruocco MR, Granato G, Sacco AM, Montagnani S.

Biomed Res Int. 2016;2016:4502846. doi: 10.1155/2016/4502846. Review.

8.

Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model.

Yoshida M, Miyasaka Y, Ohuchida K, Okumura T, Zheng B, Torata N, Fujita H, Nabae T, Manabe T, Shimamoto M, Ohtsuka T, Mizumoto K, Nakamura M.

Cancer Sci. 2016 Oct;107(10):1443-1452. doi: 10.1111/cas.13024.

9.

The TGFβ-SMAD3 pathway inhibits IL-1α induced interactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migration.

Tjomsland V, Sandnes D, Pomianowska E, Cizmovic ST, Aasrum M, Brusevold IJ, Christoffersen T, Gladhaug IP.

J Exp Clin Cancer Res. 2016 Jul 29;35(1):122. doi: 10.1186/s13046-016-0400-5.

10.

miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer.

Mühlberg L, Kühnemuth B, Costello E, Shaw V, Sipos B, Huber M, Griesmann H, Krug S, Schober M, Gress TM, Michl P.

Oncoimmunology. 2016 May 9;5(6):e1160181. doi: 10.1080/2162402X.2016.1160181.

PMID:
27471627
11.

Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response.

Cappello P, Tonoli E, Curto R, Giordano D, Giovarelli M, Novelli F.

Oncoimmunology. 2015 Dec 21;5(5):e1112940. doi: 10.1080/2162402X.2015.1112940.

12.

Profile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: Regulation by IL-1α and TGFβ and Implications for Migration of Pancreatic Cancer Cells.

Tjomsland V, Pomianowska E, Aasrum M, Sandnes D, Verbeke CS, Gladhaug IP.

Neoplasia. 2016 Jul;18(7):447-56. doi: 10.1016/j.neo.2016.06.003.

13.

Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.

Diana A, Wang LM, D'Costa Z, Allen P, Azad A, Silva MA, Soonawalla Z, Liu S, McKenna WG, Muschel RJ, Fokas E.

Oncotarget. 2016 Jul 5;7(27):40992-41004. doi: 10.18632/oncotarget.10038.

14.

Building up the tension between the epithelial and stromal compartment in pancreatic ductal adenocarcinoma.

Biffi G, Öhlund D, Tuveson D.

Cell Death Differ. 2016 Aug;23(8):1265-6. doi: 10.1038/cdd.2016.50. No abstract available.

PMID:
27285108
15.

Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review.

Yako YY, Kruger D, Smith M, Brand M.

PLoS One. 2016 May 12;11(5):e0154016. doi: 10.1371/journal.pone.0154016.

16.

Targeting inflammation in pancreatic cancer: Clinical translation.

Steele CW, Kaur Gill NA, Jamieson NB, Carter CR.

World J Gastrointest Oncol. 2016 Apr 15;8(4):380-8. doi: 10.4251/wjgo.v8.i4.380. Review.

17.

Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.

Laklai H, Miroshnikova YA, Pickup MW, Collisson EA, Kim GE, Barrett AS, Hill RC, Lakins JN, Schlaepfer DD, Mouw JK, LeBleu VS, Roy N, Novitskiy SV, Johansen JS, Poli V, Kalluri R, Iacobuzio-Donahue CA, Wood LD, Hebrok M, Hansen K, Moses HL, Weaver VM.

Nat Med. 2016 May;22(5):497-505. doi: 10.1038/nm.4082.

18.

Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation.

Tape CJ, Ling S, Dimitriadi M, McMahon KM, Worboys JD, Leong HS, Norrie IC, Miller CJ, Poulogiannis G, Lauffenburger DA, Jørgensen C.

Cell. 2016 May 5;165(4):910-20. doi: 10.1016/j.cell.2016.03.029. Erratum in: Cell. 2016 Jun 16;165(7):1818.

19.

A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.

Indolfi L, Ligorio M, Ting DT, Xega K, Tzafriri AR, Bersani F, Aceto N, Thapar V, Fuchs BC, Deshpande V, Baker AB, Ferrone CR, Haber DA, Langer R, Clark JW, Edelman ER.

Biomaterials. 2016 Jul;93:71-82. doi: 10.1016/j.biomaterials.2016.03.044.

PMID:
27082874
20.

Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma.

Carapuça EF, Gemenetzidis E, Feig C, Bapiro TE, Williams MD, Wilson AS, Delvecchio FR, Arumugam P, Grose RP, Lemoine NR, Richards FM, Kocher HM.

J Pathol. 2016 Jul;239(3):286-96. doi: 10.1002/path.4727.

Items per page

Supplemental Content

Support Center